168 related articles for article (PubMed ID: 21365325)
1. Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis.
Yuasa T; Urakami S; Yamamoto S; Yonese J; Saito K; Takahashi S; Hatake K; Fukui I
Clin Exp Metastasis; 2011 Apr; 28(4):405-11. PubMed ID: 21365325
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
3. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of multimodal treatment outcome in renal cell carcinoma patients with bone metastasis].
Mukai S; Tsukino H; Goto T; Sugie S; Shitamura T; Kamimura T; Kamoto T
Hinyokika Kiyo; 2013 Apr; 59(4):207-12. PubMed ID: 23635454
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
Urol Oncol; 2016 Oct; 34(10):433.e1-8. PubMed ID: 27321354
[TBL] [Abstract][Full Text] [Related]
6. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
[TBL] [Abstract][Full Text] [Related]
7. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and prognosis of renal cell carcinoma patients with bone metastases].
Zhai JP; Liu N; Wang H; Wang HD; Man LB
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1068-1071. PubMed ID: 32294868
[No Abstract] [Full Text] [Related]
9. Clinical outcome of patients with pancreatic metastases from renal cell cancer.
Yuasa T; Inoshita N; Saiura A; Yamamoto S; Urakami S; Masuda H; Fujii Y; Fukui I; Ishikawa Y; Yonese J
BMC Cancer; 2015 Feb; 15():46. PubMed ID: 25872621
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of brain metastasis of renal cell carcinoma.
Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
[TBL] [Abstract][Full Text] [Related]
11. Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan.
Kitamura H; Takahashi A; Takei F; Hotta H; Miyao N; Shindo T; Igarashi M; Tachiki H; Kunishima Y; Muranaka T; Shigyo M; Ikehata Y; Masumori N;
Anticancer Res; 2016 Oct; 36(10):5531-5536. PubMed ID: 27798926
[TBL] [Abstract][Full Text] [Related]
12. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma.
Higuchi T; Yamamoto N; Hayashi K; Takeuchi A; Abe K; Taniguchi Y; Kato S; Murakami H; Tsuchiya H
Bone Joint J; 2018 Sep; 100-B(9):1241-1248. PubMed ID: 30168767
[TBL] [Abstract][Full Text] [Related]
13. Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma.
Heianna J; Makino W; Ariga T; Ishikawa K; Kusada T; Maemoto H; Toguchi M; Ito J; Goya M; Miyazato M; Iraha Y; Murayama S
Eur Radiol; 2020 Mar; 30(3):1525-1533. PubMed ID: 31728686
[TBL] [Abstract][Full Text] [Related]
14. Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification.
Choong CV; Tang T; Chay WY; Goh C; Tay MH; Zam NA; Tan PH; Tan MH
Chin J Cancer; 2011 Feb; 30(2):144-8. PubMed ID: 21272447
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
16. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
Grünwald V; Eberhardt B; Bex A; Flörcken A; Gauler T; Derlin T; Panzica M; Dürr HR; Grötz KA; Giles RH; von Falck C; Graser A; Muacevic A; Staehler M
Nat Rev Urol; 2018 Aug; 15(8):511-521. PubMed ID: 29904105
[TBL] [Abstract][Full Text] [Related]
17. Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.
Lu X; Gu W; Zhang H; Zhu Y; Shi G; Ye D
Oncotarget; 2016 May; 7(18):26879-87. PubMed ID: 27058898
[TBL] [Abstract][Full Text] [Related]
18. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
Seaman E; Goluboff ET; Ross S; Sawczuk IS
Urology; 1996 Nov; 48(5):692-5. PubMed ID: 8911510
[TBL] [Abstract][Full Text] [Related]
19. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
20. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]